ag 1295 has been researched along with Leukemia, Myeloid in 1 studies
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mahboobi, S | 1 |
Uecker, A | 1 |
Sellmer, A | 1 |
Cénac, C | 1 |
Höcher, H | 1 |
Pongratz, H | 1 |
Eichhorn, E | 1 |
Hufsky, H | 1 |
Trümpler, A | 1 |
Sicker, M | 1 |
Heidel, F | 1 |
Fischer, T | 1 |
Stocking, C | 1 |
Elz, S | 1 |
Böhmer, FD | 1 |
Dove, S | 1 |
1 other study available for ag 1295 and Leukemia, Myeloid
Article | Year |
---|---|
Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase.
Topics: Acute Disease; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line; Cell Line, Tumor | 2006 |